Forbes Earnings Preview: Edwards Lifesciences

Wall Street is expecting higher profit for Edwards Lifesciences (EW) when the company reports its fourth quarter results on Monday, February 4, 2013. The consensus estimate is calling for profit of 77 cents a share, a rise from 62 cents per share a year ago.